Citations for
1CXCL9, CXCR3
Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease.
Schroepf S, Kappler R, Brand S, Prell C, Lohse P, Glas J, Hoster E, Helmbrecht J, Ballauff A, Berger M, von Schweinitz D, Koletzko S, Lacher M.
Inflamm Bowel Dis nflamm Bowel Dis. 2010 Apr 30. [Epub ahead of print]PMID: 20848514 2010
2CXCL10, CXCL9
CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors.
Rosenblum JM, Shimoda N, Schenk AD, Zhang H, Kish DD, Keslar K, Farber JM, Fairchild RL.
J Immunol 184(7):3450-60. Epub 2010 Mar 1.PMID: 20194716 2010
3CXCL9
G-protein-coupled receptor independent, immunomodulatory properties of chemokine CXCL9.
Gong JH, Nicholls EF, Elliott MR, Brown KL, Hokamp K, Roche FM, Cheung CY, Falsafi R, Brinkman FS, Bowdish DM, Hancock RE.
Cell Immunol 261(2):105-13. Epub 2009 Dec 3.PMID: 20038462 2010
4CXCL10, CXCL11, CXCL9, CXCR3
Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design.
Trotta T, Costantini S, Colonna G.
Mol Immunol 47(2-3):332-9. Epub 2009 Oct 1.PMID: 19800124 2009
5CXCL9, CXCR3
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Wasmuth HE, Lammert F, Zaldivar MM, Weiskirchen R, Hellerbrand C, Scholten D, Berres ML, Zimmermann H, Streetz KL, Tacke F, Hillebrandt S, Schmitz P, Keppeler H, Berg T, Dahl E, Gassler N, Friedman SL, Trautwein C.
Gastroenterology 137(1):309-19, 319.e1-3. Epub 2009 Apr 1.PMID: 19344719 2009
6CXCL9
Dysregulation of CXCL9 and reduced tumor growth in Egr-1 deficient mice.
Caso G, Barry C, Patejunas G.
J Hematol Oncol 2:7.PMID: 19200397 2009
7CXCL9
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
Menke J, Zeller GC, Kikawada E, Means TK, Huang XR, Lan HY, Lu B, Farber J, Luster AD, Kelley VR.
J Am Soc Nephrol 19(6):1177-89. Epub 2008 Mar 12.PMID: 18337479 2008
8CXCL9
The antibacterial chemokine MIG/CXCL9 is constitutively expressed in epithelial cells of the male urogenital tract and is present in seminal plasma.
Linge HM, Collin M, Giwercman A, Malm J, Bjartell A, Egesten A.
J Interferon Cytokine Res 28(3):191-6.PMID: 18338951 2008
9CXCL9
Association of a CXCL9 polymorphism with pediatric Crohn's disease.
Lacher M, Kappler R, Berkholz S, Baurecht H, von Schweinitz D, Koletzko S.
Biochem Biophys Res Commun 363(3):701-7. Epub 2007 Sep 18. 2007
10CXCL9
Close resemblance between chemokine receptor expression profiles of lymphoproliferative disease of granular lymphocytes and their normal counterparts in association with elevated serum concentrations of IP-10 and MIG.
Momose K, Makishima H, Ito T, Nakazawa H, Shimodaira S, Kiyosawa K, Ishida F.
Int J Hematol 86(2):174-9.PMID: 17875534 2007
11CXCR3, CXCl9, CXCL10, CXCL11
Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
Xanthou G, Williams TJ, Pease JE.
Eur J Immunol 33(10):2927-36. 2003
12CXCL10, CXCL11, CXCL9
High-resolution mapping of the human 4q21 and the mouse 5E3 SCYB chemokine cluster by fiber-fluorescence in situ hybridization
Erdel M, Theurl M, Meyer M, Duba HC, Utermann G, Werner-Felmayer G.
Immunogenetics 53(7):611-5. 2001
13CXCL9, CXCL10
Localization of the gene for the human MIG cytokine on chromosome 4q21 adjacent to INP10 reveals a chemokine mini-cluster.
Lee HH, et al.
Cytogenet Cell Genet 74 : 255-258. 1996